Propionyl-l-carnitine improves endothelial function, microcirculation and pain management in critical limb ischemia

Cardiovascular Drugs and Therapy

Volumn 26, Issue 5, 2012, Pages 401-408

  De Marchi, S ^a,c   Zecchetto, S ^a   Rigoni, A ^a   Prior, M ^a   Fondrieschi, L ^a   Scuro, A ^b   Rulfo, F ^a   Arosio, E ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Ospedale Policlinico   (Italy)

Author keywords

Carnitine; Critical limb ischemia; Endothelium; Laser Doppler

Indexed keywords

PARACETAMOL; PLACEBO; PROPIONYLCARNITINE; TRAMADOL;

AGED; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; OXYGEN TENSION; PAIN; PAIN ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN BLOOD FLOW; VASCULAR ENDOTHELIUM; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GAS MONITORING, TRANSCUTANEOUS; BRACHIAL ARTERY; CARNITINE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LEG; MALE; MICROCIRCULATION; PAIN MANAGEMENT; PERIPHERAL ARTERIAL DISEASE; REGIONAL BLOOD FLOW; VASODILATION;

EID: 84867946640     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-012-6408-y     Document Type: Article

References (38)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Department of Surgery, University Hospital, Orebro, Sweden. J Vasc Surg. 2007;45:S5-67.
2. Second european consensus document on chronic critical leg ischemia. Circulation 1991;84:1-26.
3. Dormandy JA, Heeck L, Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg. 1999;12:142-7. (Pubitemid 29259202)
4. Nash GB, Thomas PRS, Dormandy J. Abnormal flow properties of white cells in patients with severe ischaemia of the leg. Br Med J. 1988;296:1699-701.
5. Signorelli SS, Malaponte G, Di Pino L, Digrandi D, Pennisi G, Mazzarino MC. Effects of ischemic stress on leukocyte activation process in patients with chronic peripheral occlusive arterial disease: Role of LPC administration. Pharmacol Res. 2001;44:305-9. (Pubitemid 32977922)
6. Bevilacqua MP, Pober JS, Majeau GR, Cotrau RS, Gimbrone Jr MA. Interleukin 1(1-14) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelia cells. J Exp Med. 1984;160:618.
7. Indiveri C, Tonazzi A, Palmieri F. Identification and purification of the carnitine carrier from rat liver mitochondria. Biochim Biophys Acta. 1990;1020:81-6.
8. Brevetti G, Diehm C, Lambert D. European multicentre study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol. 1999;34:1618-24. (Pubitemid 29528679)
9. Sethi R, Wang X, Ferrari R, Dhalla NS. Improvement of cardiac function and beta adrenergic signal transduction by propionyl-Lcarnitine in congestive heart failure due to myocardial infarction. Coron Artery Dis. 2004;15:65-71. (Pubitemid 39118002)
10. Lango R, Smolenski RT, Rogowski J, Siebert J, Wuitewicz M, Slominska EM, Lysiak-Szdlowska W, Yacoub MH. Propionyl-Lcarnitine improves haemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients. Cardiovasc Drug Ther. 2005;19:267-75. (Pubitemid 41778807)
11. Orlandi A, Marcellini M, Pesce D, Calvani M, Spagnoli LG. PLC reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3- dependent apoptosis of vascular smooth muscle cells. Atherosclerosis. 2002;160:81-9. (Pubitemid 34076645)
12. Cipolla MJ, Nicholoff A, Rebello T, Amato A, Porter JM. PLC dilates human subcutaneous arteries through an endothelium dependent mechanism. J Vasc Surg. 1999;29:1097-103. (Pubitemid 29284367)
13. Bueno R, Alvarez de Sotomayor M, Perez Guerrero C, Gomez Amores L, Vazquez CM, Herrera MD. L-carnitine and propionyl- L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: Different participation of NO and COX products. Life Sci. 2005;77:2082-97. (Pubitemid 41140450)
14. Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, Barcellona ML. L-propionyl-carnitine as superoxide scavenger, antioxidant and DNA cleavage protector. Cell Biol Toxicol. 2000;16:99-104. (Pubitemid 30451545)
15. Loffredo L, Pignatelli P, Cangemi R, Andreozzi P, Panico MA, Meloni V, Violi F. Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: Effect of antioxidant treatment. J Vasc Surg. 2006;44:525-30. (Pubitemid 44293200)
16. Del Guercio R. Evaluation of postischemic hyperemia on the skin using laser Doppler velocimetry: Study on patients with intermittens claudication. Microvasc Res. 1986;32:289-99. (Pubitemid 17213833)
17. De Marchi S, Prior M, Rigoni A, Zecchetto S, Rulfo F, Arosio E. Ascorbic acid prevents vascular dysfunction induced by oral glucose load in healthy subjects. Eur J Intern Med. 2012;23:54-7.
18. Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. J Hypertens. 2002;20:1793-7.
19. Arosio E, De Marchi S, Zannoni M, Prior M, Lechi A. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: A randomized, double-blind, placebo-controlled trial. Majo Clin Proc. 2002;77:754-9.
20. Larsen JF, Cristensen CR. Forefoot transcutaneous oxygen tension at different leg positions in patients with peripheral vascular disease. Eur J Vasc Surg. 1990;8:185-8.
21. Melillo E, Ferrari M, Balbarini A, Pedrinelli R. Transcutaneous oxygen and carbon dioxide levels in iloprost administration in diabetic critical limb ischemia. Vasc Endovasc Surg. 2006;40:303-11. (Pubitemid 44450493)
22. Melillo E, Nuti M, Pedrinelli R, Buttitta F, Balbarini A. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short and long term therapeutic management of non reconstructable lower critical limb ischemia? Minerva Cardioangiol. 2006;54:481-98. (Pubitemid 44689844)
23. Gersbach PA, Argitis V, Gardaz JP, von Segesser LK, Haesler E. Late outcome of spinal cord stimulation for unreconstructable and limb-treatening lower limb ischemia. Eur J Vasc Endovasc Surg. 2007;33:717-24. (Pubitemid 46672812)
24. Andreozzi GM, Rigigo F, Butto' G, Barresi M, Leone A, Pennisi G, Martini R, Signorelli S. Transcutaneous PCO2 level as an index of tissue resistance to ischemia. Angiology. 1995;46:1097-102.
25. Celemajer DS, Sorensen KE, Goock VM, Spieghelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-5.
26. Sorensen KE, Celermajer DS, Spiegelhalter DJ. Non-invasive measurement of endothelium-dependent arterial responses in man: Accuracy and reproducibility. Br Heart J. 1995;74:247-53.
27. Takase B, Uehata A, Akima T. Endothelium-dependent flowmediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol. 1998;82:1535-9. (Pubitemid 29006482)
28. Arosio E, De Marchi S, Rigoni A, Prior M, Delva P, Lechi A. Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens. 2007;25:1273-8. (Pubitemid 46918807)
29. Ruger LJ, Irnich D, Abaji TN, Crispin A, Hoffmann U, Lang PM. Characteristics of chronic ischemic pain in patients with peripheral arterial disease. Pain. 2008;139:201-8.
30. Milio G, Novo G, Genova C, Almasio PL, Novo S, Pinto A. Pharmacological treatment of patients with chronic critical limb ischemia: L-propionyl-carnitine enhances the short-term effects of PGE-1. Cardiovasc Drugs Ther. 2009;23:301-6.
31. Calo LA, Pagnin E, Davis PA, Semplicini A, Nicolai R, Calvani M, Pessina AC. Antioxidant effect of L-carnitine and its short chain esters: Relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol. 2006;107:54-60. (Pubitemid 41767518)
32. Vita JA, Hamburg NM. Does endothelial dysfunction contribute to the clinical status of patients with peripheral arterial disease? Can J Cardiol. 2010;26:45A-50.
33. StasiMS, Scioli MG, Arcuri G,Mattera GG, Lombardo K,Marcellini M, Riccioni T, De Falco S, Pisano C, Spagnoli LG, Borsini F, Orlandi A. Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPHoxidase 4mediated superoxyde production. Arterioscler Thromb Vasc Biol. 2010;30:426-35.
34. Allegra C, Antignani PL, Schacter I, Koverech A, Messano M, Virmani A. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease. Ann Vasc Surg. 2008;22:552-8.
35. Packer L, Valenza M, Serbinova E, Starke-Reed P, Frost K, Kagan V. Free radical scavenging is involved in the protective effect of Lpropionyl- carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys. 1991;288:533-7.
36. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: A review. Ann N YAcad Sci. 2004;1033:79-91. (Pubitemid 39656740)
37. Melillo E, Nuti M, Pedrinelli R, Buttitta F, Balbarini A. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of nonreconstructable lower critical limb ischemia? Minerva Cardioangiol. 2006;54:481-98. (Pubitemid 44689844)
38. McMackin CJ, Widlansky ME, Hamburg NM, Huang AL, Weller S, Holbrook M, Gocke N, Hagen TM, Keaney JF, Vita JA. Effect of combined treatment with alpha-lipoic acid and acetyl-Lcarnitine on vascular function and blood pressure in patients with coronary artery disease. Clin Hypertens. 2007;9:249-55.